Effect of blood gas derangement on QTc dispersion in severe chronic obstructive pulmonary disease: evidence of an electropathy?


      Cardiac arrhythmias are common in patients with respiratory failure from chronic obstructive pulmonary disease (COPD). Several factors may be potentially arrhythmogenic in these patients, including hypoxemia and hypercapnia, acid-base disturbances, cor pulmonale and the use of digitalis, methylxanthines, and sympathomimetic drugs. The aim of this study was to examine the effect of hypoxemia and hypercapnia on QTc dispersion (QTcD) in COPD patients, and to evaluate the effect of a partial correction of one of these pro-arrhythmic factors, the hypoxemia, on Qtc dispersion, as QTcD has been proposed as a marker of heterogeneous repolarization and, hence of ventricular electrical instability. We showed that in 15 hypoxemic/hypercapnic COPD patients, compared to 20 controls, the QTcD was significantly higher (49.7±10.6 vs. 22.9±9.8 ms; P=0.0001); furthermore, after only 24 h of oxygen therapy, and hence after a partial correction of hypoxemia, there was a significant reduction in QTcD in COPD patients (49.7±10.6 vs. 36.3±10.1 ms; P=0.018). The data of the present study suggest that the increase in QTcD may be an early marker of a blood gas mediated electropathy in COPD patients.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Shih HT, Webb CR, Conway WA, Peterson E, Tilley B, Goldstein S. Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest 1988; 94: 44–48.

      2. Antonelli Incalzi R, Pistelli R, Fuso L, Cocchi A, Bonetti MG, Giordano A. Cardiac arrhythmias and left ventricular function in respiratory failure from chronic obstructive pulmonary disease. Chest 1990; 5: 1092–1097.

      3. Tirlapur VG, Mir MA. Nocturnal hypoxemia and associated electrocardiographic changes in patients with chronic obstructive airway disease. N Engl J Med 1982; 306: 125–130.

      4. Levine PA, Klein MD. Mechanisms of arrhythmias in chronic obstructive lung disease. Geriatrics 1976; 31: 47–56.

      5. Biggs FD, Lefrak SS, Kleiger RE, Senior RM, Oliver GC. Disturbances of rhythm in chronic lung disease. Heart Lung 1977; 6: 256–261.

      6. Green LH, Smith TW. The use of digitalis in patients with pulmonary disease. Ann Intern Med 1977; 87: 459–465.

      7. Bittar G, Friedman HS. The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. Chest 1991; 99: 1415–1420.

      8. Conradson TB, Eklundh G, Olofsson B, Pahlm O, Persson G. Cardiac arrhythmias in patients with mild to moderate obstructive lung disease. Comparison of beta-agonist therapy alone and in combination with a xanthine derivative, enprophylline or theophylline. Chest 1985; 88: 537–542.

      9. Josephson GW, Kennedy HL, Mackenzie EJ, Gibson G. Cardiac dysrhythmias during the treatment of acute asthma. Chest 1980; 78: 429–435.

      10. Pierson DJ, Hudson LD, Stark K, Hedgecock M. Cardiopulmonary effects of terbutaline and a bronchodilatator combination in chronic obstructive pulmonary disease. Chest 1980; 77: 176–182.

      11. Davies SW, John LM, Wedzicha JA, Lipkin DP. Overnight studies in severe chronic left heart failure: arrhythmias and oxygen desaturation. Br Heart J 1991; 65: 77–83.

      12. Coccagna G, Lugaresi E. Arterial blood gases and pulmonary and systemic pressure during sleep in chronic obstructive pulmonary disease. Sleep 1978; 1: 117–124.

      13. Boysen PG, Block AJ, Wynne JW, Hunt LA, Flick MR. Nocturnal pulmonary hypertension in patients with chronic obstructive pulmonary disease. Chest 1979; 76: 536–542.

      14. Douglas NJ, Calverley PMA, Leggett RJE, Brash HM, Fenley DC, Brezinova V. Transient hypoxaemia during sleep in chronic bronchitis and emphysema. Lancet 1979; i: 1–4.

      15. Day CP, McComb JM, Campbell RWF. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990; 63: 342–344.

      16. Han J, Moe GK. Nonuniform recovery of excitability in ventricular muscle. Circ Res 1964; 14: 44–60.

      17. Zabel M, Portnoy S, Franz MR. Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol 1995; 25: 746–752.

      18. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 1920; 7: 353–370.

      19. Pye M, Ferrel TG, Cobbe SM. QT interval dispersion in patients with sustained ventricular tachycardia or fibrillation (abstract). Eur Heart J 1992; 13(Suppl.): 221.

      20. Bonatti V, Rolti A, Bolti G. Recording of monophasic action potentials of right ventricle in long QT syndromes complicated by ventricular arrhythmias. Eur Heart J 1983; 4: 168–174.

      21. Merx W, Yoon MS, Han J. The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation. Am Heart J 1977; 94: 603–612.

      22. Reynolds RJ, Buford JG, George RB. Treating asthma and COPD in patients with heart disease. J Respir Dis 1982; 3: 41–51.

      23. Scarduelli C, Sella D, Rosa A, Belfanti D, Buzzi G, Guerra G, Sturani C. Aritmie cardiache nella insufficienza respiratoria cronica da broncopneumopatia cronica ostruttiva: incidenza e correlazione con le turbe respiratorie notturne. Cardiologia 1991; 5: 379–384.

      24. Linker NJ, Colonna P, Kekwick CA, Till J, Camm J, Ward DE. Assessment of QT dispersion in symptomatic patients with congenital long QT syndromes. Am J Cardiol 1992; 69: 634–638.

      25. Priori SG, Napolitano C, Diehl L, Schwartz PJ. Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 1994; 89: 1681–1689.

      26. Day CP, McComb JM, Campbell RWF. Reduction in QT dispersion by sotalol following myocardial infarction. Eur Heart J 1991; 12: 423–427.

      27. Zareba W, Moss AJ, le Cassie S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol 1994; 74: 550–553.

      28. Glancy JM, Garratt CJ, Woods KL, de Bono DP. QT dispersion and mortality after myocardial infarction. Lancet 1995; 345: 945–948.

      29. Higham PD, Furniss SS, Campbell RWF. QT dispersion and components of the QT interval in ischaemia and infarction. Br Heart J 1995; 73: 32–36.

      30. Silverman HS, Stern MD. Ionic basis of ischaemic cardiac injury: insights from cellular studies. Cardiovasc Res 1994; 28: 581–597.

      31. Janse MJ, Wit AS. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 1989; 69: 1049–1169.

      32. Vankatesh N, Lamp ST, Weiss JM. Sulfonylureas, ATP sensitive potassium channels and cellular K loss during hypoxia, ischemia and metabolic inhibition in mammalian ventricle. Circ Res 1991; 69: 623–637.

      33. Billman GE. Role of ATP sensitive potassium channel in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischemia. Cardiovasc Res 1994; 28: 251–258.

      34. Coronel R. Heterogeneity in extracellular potassium concentration during early myocardial ischaemia and reperfusion: implication for arrhythmogenesis. Cardiovasc Res 1994; 28: 770–777.